Schizoaffective Disorders Completed Phase 4 Trials for Lurasidone (DB08815)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02199743Lurasidone Effects on Tissue Glutamate in SchizophreniaTreatment